tmp20CA TMP

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

50# 100"

PHLMS&Acceptance&Scores(

BAFT%Scores!
40# 80"
60"
30#
40"
20# 20"
10# 0"
#

1#

#
3#

7#

"

1"

3"

7"

"

"

"
ke

10

U.

U.

ke

10

U.

U.
#F.

#F .

"F.

"F .
ta

ta
In

In
o.

ar

o.

ar
m

m
ye

ye
1#

1"
3#

3"
a)&&&&&&&&&&&&&&&&&&&&&&&&&Session&Number&& b)%%%%%%%%%%%%%%%%%%%%%%%%%Session%Number%%

30" 170#
AAQ#2%Total%Scores!

KMPAI&Scores!
25"
20" 120#
15"
10" 70#
5"
0" 20#
1"

"
3"

7"

"

"

1#

3#

7#

#
10

U.

U.

ke

10

U.

U.
"F.

"F .

#F.

#F .
ta
In
o.

ar

o.

ar
m

m
ye

ye
1"

1#
3"

3#
c)%%%%%%%%%%%%%%%%%%%%%%%%%Session%Number%% d)&&&&&&&&&&&&&&&&&&&&&&&&&Session&Number&&

Figure 2. a) PHLMS Acceptance subscale scores, and b) BAFT scores from intake (baseline) to
1-month follow-up and 3-year follow-up (June 2017) with non-clinical means and bars spanning
two standard deviations, bidirectionally. c) AAQ-2 scores from session 1 to 1-month follow-up
and 3-year follow-up (June 2017) with non-clinical mean and bars spanning two standard
deviations, bidirectionally. d) KMPAI scores from intake to 1-month follow-up and 3-year
follow-up (June 2017) with cutoff score for determining clinically significant levels of MPA.

You might also like